SICC Innvierte from CDTI Innovación, in collaboration with Sofinnova Capital X, is investing in Nuage Tx, a startup developing new drugs that target proteins previously considered undruggable (Intrinsically Disordered Proteins, IDPs)
With this investment, Nuage Tx seeks to advance the development of their technology to bring his first product therapeutic oncological patients
CDTI Innovación, through its Innvierte initiative and in collaboration with Sofinnova Capital X, has reached an agreement with NUAGE PHARMACEUTICALS, S.L. (Nuage Tx) to invest in the company. The amount committed by CDTI Innovación is €1.8 million.
Nuage Tx was founded in Barcelona in 2021 by Dr. Xavier Salvatella and Dr. Mateusz Biesaga from the Institute for Research in Biomedicine (IRB Barcelona), together with Dr. Denes Hnisz from the Max Planck Institute in Berlin. The company, currently led by Stuart Hughes, is developing new drugs targeting pharmacological proteins that, until now, have been considered undruggable by the pharmaceutical industry due to their lack of defined structure commonly known as Intrinsically Disordered Proteins (IDPs). Nuage Tx aims to shift the paradigm in how IDPs are approached, transforming them from “undruggable” to “druggable” targets.
With this investment, Nuage Tx aims to advance the development of its technology and bring its first therapeutic product to oncology patients.
In addition to this agreement, CDTI Innovación has completed other investments in Nuage Tx in partnership with Asabys, for a total amount of nearly €3 million.
Sofinnova Partners
Sofinnova Partners is a leader in risk capital in life sciences, specializing in the industry of health and sustainability. Based in paris, london and Milan, the team brings together professionals from around the world with a solid scientific, medical and management.
Sofinnova Partners is a active in the creation of businesses throughout the value chain of investments in life sciences, from the seed to more advanced steps.
Founded in 1972, Sofinnova Partners is a risk capital deeply established in europe with 50 years of experience, to support more than 500 companies and creating market leaders around the world. Today, manages over eur 4 billion in assets.
Innvierte
Innvierteit is an initiative aimed at promoting the entrepreneurial innovation through support to the risk capital investment in technology-based enterprises or innovative programme. This is done through the collective investment type closed Innvierte Sustainable Economy SICC S.M.E., S.A., self-managed and under the supervision of the national Values and that the CDTI Innovation is a shareholder Only.
To date, the CDTI Innovation, through Innvierte, committed 1.875 M €in 55 investment vehicles that have invested in more than 599 companies, and through its joint investment line directly committed an amount of 601 M €in 178 companies.
Innvierte fits into the strategy for science, technology and innovation 2021-2027, adopted by decision of the council of ministers, in september. This 2020 Strategy contains goals, the reforms and measures to be taken throughout the area of r + D + i in order to boost their growth and impact, and is one of the pillars on which the design of the government's policy in r + D + i for the coming years.
CDTI Innovation
The centre for technological development and innovation, CDTI E.P.E. is a public company under the ministry of Science, innovation and universities, whose goal is the promotion of technological innovation in business. The CDTI mission is to ensure that the business fabric english generates and transform knowledge into growth científico-técnico globally competitive, sustainable and inclusive. By 2024, within the framework of a new strategic plan, the CDTI provided more than $2.3 billion euros of support for business startups and spain.
More information:
Office of the press
prensa@cdti.es
91-581.55.00
On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
X:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial
This content is copyright © 2025 CDTI, Soes. Permitted for use and reproduction by quoting the source and digital identity of CDTI (@CDTI _ innovation).